Position in CRSP
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,308
+$934 QoQ
Shares Held
134
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#407
of 519 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Front Row Advisors LLC holds $551,277 across 11 Biotechnology names. CRSP ranks #3 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABUS |
Arbutus Biopharma Corp
|
110,500 | $530,400 | |
| 2 | BNTX |
BioNTech SE
|
80 | $7,444 | |
| 3 | CRSP |
CRISPR Therapeutics AG
This page
|
134 | $7,308 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
9 | $2,168 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7 | $2,107 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2 | $1,247 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
15 | $585 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
|
2 | $13 |
All Filings in CRSP
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,308 | 134 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $6,374 | 134 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $7,026 | 134 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $8,684 | 134 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $5,642 | 116 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $3,947 | 116 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,565 | 116 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $5,449 | 116 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,265 | 116 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $7,906 | 116 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $7,261 | 116 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $37,946 | 836 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $935,741 | 16,668 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $781,031 | 17,268 | Shares | Sole | 2023-05-23 | |
| 2022-12-31 | $709,261 | 17,448 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $1,232,043 | 18,853 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $1,163,137 | 19,140 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,202,673 | 19,160 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,444,366 | 19,060 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $1,988,548 | 17,766 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $2,839,712 | 17,541 | Shares | Sole | 2021-08-23 | |
| 2021-03-31 | $2,010,281 | 16,498 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $2,443,941 | 15,962 | Shares | Sole | 2021-02-25 | |
| 2020-09-30 | $1,351,371 | 16,157 | Shares | Sole | 2020-11-30 | |
| 2020-06-30 | $1,217,508 | 16,567 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $711,300 | 16,772 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||